白云山 (600332.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

9.0x

Market Cap

CNY 32.70B

MomentumView details →

1D Return

−3.83%

YTD Return

−21.37%

RSI (14)

36.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

9.0x

Market Cap

CNY 32.70B

RSI (14)

36.4

MomentumView details →

1D Return

−3.83%

YTD Return

−21.37%

ProfitabilityView details →

Gross Margin

16.22%

Net Margin

3.75%

EBITDA Margin

5.55%

ROE (TTM)

7.45%

ROA (TTM)

3.28%

Asset Turnover

0.90x

GrowthView details →

Revenue YoY

+5.29%

EPS YoY

+9.16%

FCF YoY

−87.31%

Revenue CAGR 3Y

+3.13%

EPS CAGR 3Y

−9.06%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.19

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−0.96%

Capital & dividendView details →

Debt/Equity

0.42x

Current Ratio

1.60x

Quick Ratio

1.29x

Div Yield

4.20%

Div Rate

CNY 0.85

Div Growth 1Y

−43.75%

Financials snapshotView financials →

Revenue (TTM)

78.46B

Net Income (TTM)

2.95B

Op. CF (TTM)

1.45B

Next earningsOct 27, 2026 →

Latest newsMore news →

Singapore biotech company LionTCR will work with Guangzhou Pharmaceutical Holdings to develop and accelerate the clinical translation of TCR-T cell therapies.9d ago

Baiyunshan and other parties jointly established Hongyang Health Technology (Yangzhou) Co., Ltd., a health technology company in Yangzhou, China, with Li Jin as legal representative, covering cosmetics production and daily necessities sales.11d ago

Similar companies

Zoetis Inc.ZTS ST人福600079.SH China Resources Pharmaceutical Group Limited03320.HK 达仁堂600329.SH China Medical System Holdings Limited00867.HK Haleon plcHLN Find similar companies →

Latest newsMore news →

Singapore biotech company LionTCR will work with Guangzhou Pharmaceutical Holdings to develop and accelerate the clinical translation of TCR-T cell therapies.9d ago Baiyunshan and other parties jointly established Hongyang Health Technology (Yangzhou) Co., Ltd., a health technology company in Yangzhou, China, with Li Jin as legal representative, covering cosmetics production and daily necessities sales.11d ago Guangzhou Baiyunshan Hejigong Pharmaceutical Co., Ltd., a subsidiary of Guangzhou Pharmaceutical Holdings Limited, acquired a controlling stake in Beijing Fama Star Pharmaceutical Technology Co., Ltd. for 330 million yuan.39d ago